| Literature DB >> 33677730 |
Mizuho Takayanagi1, Yoko Kawasaki2, Mieko Shinomiya2, Hoshino Hiroshi3, Satoshi Okada4, Tamiko Ino2, Kazuko Sakai2, Kimiko Murakami2, Rie Ishida2, Kaoru Mizuno2, Shin-Ichi Niwa3.
Abstract
This study was a systematic review of research using the Wechsler Intelligence Scale for Children (WISC) with Autism Spectrum Disorder (ASD) to examine cognitive characteristics of children with ASD beyond the impact of revisions based on WISC and diagnostic criteria changes. The classic "islets of ability" was found in individuals with full-scale IQs < 100. The "right-descending profiles" were observed among high IQ score individuals. High levels on the Block Design and low Coding levels were consistently found regardless of the variation in intellectual functioning or diagnosis. This review identified patterns of cognitive characteristics in ASD individuals using empirical data that researchers may have previously been aware of, based on their experiences, owing to the increased prevalence of ASD.Entities:
Keywords: Autism spectrum disorder (ASD); Cognitive function; Intelligence ability; Systematic review; Wechsler scales
Mesh:
Year: 2021 PMID: 33677730 PMCID: PMC8732936 DOI: 10.1007/s10803-021-04932-x
Source DB: PubMed Journal: J Autism Dev Disord ISSN: 0162-3257
Studies on the WISC related to autism spectrum extracted by systematic review
| Reference Number | Authors and Year of Publication | Participant Groups | Ultimately Analyzed Participants | Diagnosis | Age (y) | Age (y) Range | FSIQ | Test(s) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Lockyer and Rutter ( | Infantile psychosis | 21 | 15.7 | – | 74.2 | WISC/WAIS | ||
| 2 | Bartak et al. ( | † | Infantile autism | 9 | – | 4.5–9.9 | – | WISC | |
| 3 | Tymchuk et al. ( | Childhood psychosis | 20 | 15.9 | – | 88 | WISC/WAIS | ||
| 4 | Freeman et al. ( | † | Autistic children | 21 | 8.8 | 6–12 | 97.4 | WISC-R | |
| 5 | Ohta ( | † | Infantile autism | 16 | 10.2 | 6–14 | 72.1 | WISC | |
| 6 | Asarnow et al. ( | Infantile autism | 23 | 10.4 | – | 91.4 | WISC-R | ||
| 7 | Lincoln et al. ( | † | Infantile autism | 13 | – | 8–12 | 68.5 | WISC-R | |
| 8 | Szatmari et al. ( | S1 | Autism | 17 | 22.8 | 7–32 | 82.2 | WISC-R/WAIS-R | |
| S2 | Asperger’s syndrome | 26 | 14.3 | 8–18 | 86.6 | WISC-R/WAIS-R | |||
| 9 | Allen et al. ( | † | Autistic children | 20 | 10.3 | 6–12 | 68.4 | WISC-R | |
| 10 | Venter et al. ( | Autism | 58 | 14.7 | 10–37 | 79.2 | WISC-R/WAIS-R | ||
| 11 | Happe ( | Autism | 51 | 15.4 | 7–25 | 62.1 | WISC-R/WAIS | ||
| 12 | Siegel et al. ( | † | Autism | 45 | 10.1 | 6–16 | 96 | WISC-R | |
| 13 | Ehlers et al. ( | E1 | † | Infantile autism/ Autistic disorder | 40 | 9.9 | 6.1–15.8 | 78.8 | WISC-R |
| E2 | † | Asperger syndrome | 40 | 9.8 | 5.3–15 | 102.5 | WISC-R | ||
| 14 | Manjiviona and Prior ( | M1 | † | Autism | 21 | 11.6 | 7–15 | 88.61 | WISC-R |
| M2 | Asperger syndrome | 35 | 10.4 | 6–17 | 102.6 | WISC-R/WAIS-R | |||
| 15 | Ozonoff et al. ( | O1 | Autism | 23 | 13.3 | 6.6–20.9 | 108.9 | WISC-III/WAIS-III | |
| O2 | Asperger syndrome | 12 | 13.9 | 6.6–20.9 | 115.6 | WISC-III/WAIS-III | |||
| 16 | Nydēn et al. ( | † | Asperger syndrome | 13 | 9.8 | 6.6–11 | 106.8 | WISC-III | |
| 17 | Bōlte et al. ( | Autism | 20 | 16.8 | 14–21.3 | 82.5 | WISC-R/WAIS-R | ||
| 18 | Mayes and Calhoun ( | Autistic disorder | 53 | 8.5 | 6–15 | 88.4 | WISC-III | ||
| 19 | Bölte and Poustka ( | Autism | 59 | 17.9 | 6.4–49.4 | 78.1 | WISC-R/WAIS-R | ||
| 20 | Cederlund and Gillberg ( | Asperger syndrome | 98 | 11.4 | 5.6–24.6 | 101 | WISC-R/WSIC-III/ WAIS-R | ||
| 21 | Ghaziuddin and Mountain-Kimchi ( | G1 | Autism | 12 | 12.4 | – | 92.2 | WISC-III/WAIS-R | |
| G2 | Asperger syndrome | 22 | 12.2 | – | 103.3 | WISC-III/WAIS-R | |||
| 22 | Mayes and Calhoun ( | † | Autism | 93 | 9 | 6–16 | 103 | WISC-III | |
| 23 | de Bruin et al. ( | B1 | † | Autism | 13 | 8.6 | 6–12 | 88.9 | WISC-R |
| B2 | † | Asperger syndrome | 11 | 8.6 | 6–12 | 106.3 | WISC-R | ||
| 24 | Koyama et al. ( | PDDNOS | 27 | 8 | 5.6–13.8 | 94.9 | WISC-III | ||
| 25 | Williams et al. ( | † | Autism | 38 | 11.7 | 8–16 | 103.8 | WISC-III | |
| 26 | Williams et al. ( | Autism | 56 | 11.4 | 8–15 | 104.1 | WISC-III | ||
| 27 | Koyama et al. ( | K1 | Autistic children | 37 | 12.6 | 5.4–30.3 | 94.6 | WISC-R/WISC-III/WAIS-R | |
| K2 | Asperger syndrome | 36 | 12.8 | 5.6–30.5 | 98.3 | WISC-R/WISC-III/WAIS-R | |||
| 28 | Muraru et al. ( | † | PDD | 53 | 9.2 | – | 97.8 | WISC-III | |
| 29 | Zhang et al. ( | † | PDD | 135 | 9 | 5–16 | 92.9 | WISC-III | |
| 30 | Koyama and Kurita ( | † | Asperger syndrome | 28 | 9.3 | 5–13 | 102.1 | WISC-III | |
| 31 | Mayes and Calhoun ( | † | Autism | 54 | 8.2 | 6–14 | 101 | WISC-IV | |
| 32 | Koyama et al. ( | † | PDD | 142 | 8.9 | – | 96.3 | WISC-III | |
| 33 | Inada and Kamio ( | ASD | 48 | 12.5 | – | 93.4 | WISC-III | ||
| 34 | Noterdaeme et al. ( | N1 | Autism | 55 | 10.6 | 6.1–19.5 | 94 | WISC-III/WAIS | |
| N2 | Asperger’s syndrome | 57 | 11.2 | 6.8–19.9 | 104.1 | WISC-III/WAIS | |||
| 35 | Charman et al. ( | ASD | 127 | 11.5 | 9.8–14.5 | 75.5 | WISC-III | ||
| 36 | Foley-Nicpon et al. ( | F1 | † | Autism | 18 | – | 6–16.2 | 120.3 | WISC-IV |
| F2 | † | Asperger syndrome | 21 | – | 6–16.2 | 124.9 | WISC-IV | ||
| 37 | Merchan-Naranjo et al. ( | Asperger syndrome | 29 | 13 | 7–17 | 96.9 | WISC-R/WAIS-III | ||
| 38 | Oliveras-Rentas et al. ( | † | ASD | 56 | 9.1 | 6–15 | 97.6 | WISC-IV | |
| 39 | Planche and Lemonnier ( | P1 | Autism | 15 | 8.1 | 6–10.1 | 98.1 | WISC-III | |
| P2 | Asperger’s syndrome | 15 | 8 | 6–9.8 | 105.5 | WISC-III | |||
| 40 | McGonigle-Chalmers and McSweeney ( | ASD | 15 | 13.7 | 12.5–15.2 | – | WISC-III | ||
| 41 | Reinvall et al. ( | Asperger syndrome | 20 | 13.5 | 12–16.1 | 103.2 | WISC-III | ||
| 42 | Kuriakose ( | † | ASD | 23 | 11.2 | 7.1–15.6 | 80 | WISC-IV | |
| 43 | Matsuura et al. ( | † | ASD | 11 | 12 | – | 105.4 | WISC-IV | |
| 44 | Zielińska et al. ( | Autism | 35 | 9.4 | – | 97.1 | WISC-R | ||
| 45 | Calero et al. ( | † | Asperger syndrome | 45 | 9.6 | 7–13 | 102.3 | WISC-IV | |
| 46 | Kumazaki et al. ( | † | ASD | 46 | 7.5 | 5–9 | 97.6 | WISC-III | |
| 47 | Nader et al. ( | N1 | † | Autism | 51 | 10.5 | 6–16 | 90.6 | WISC-III |
| N2 | † | Asperger syndrome | 15 | 11.5 | 7–15 | 99.4 | WISC-III | ||
| N3 | † | Autism | 51 | 10.6 | 7–15 | 90.7 | WISC-IV | ||
| N4 | † | Asperger syndrome | 15 | 10.6 | 7–15 | 98.3 | WISC-IV | ||
| 48 | Mouga et al. ( | M1 | † | ASD | 58 | 9.8§ | 6–16.9 | 60.9 | WISC-III |
| M2 | † | ASD | 166 | 9.8§ | 6–16.9 | 96.5 | WISC-III | ||
| 49 | Li et al. ( | † | ASD | 32 | 10.3 | 6–16 | 94.4 | WISC-IV | |
| 50 | Li et al. ( | ASD | 31 | 10.2 | 6–16 | 94.7 | WISC-IV | ||
| 51 | Stack et al. ( | † | ASD | 134 | – | 6–15.7 | 97.8 | WISC-IV |
Participant Groups: When a paper by one author contains multiple participant groups, the group names are distinguished by giving the initial letter of the author name of the group and numbers. E.g.) For Szatmari, there are 2 groups with different diagnostic groups, which are S1 and S2. For Nader, there are 4 groups with different diagnostic groups and WISC test versions, which are N1, N2, N3, and N4
The “Ultimately Analyzed Participants” refers to the group that met all selection criteria and became this study’s ultimate analysis participants. † indicates the selected groups
Reasons for exclusion) Paper numbers 1,3,8,10,15,17,19,20,21,27,34,37 and M2 of paper number14 were excluded because they included WAIS. Paper number 6 was excluded because of the original study excluded the numerical values, while the mean scores were provided elsewhere (Happe 1994). Paper number 18 was excluded because the subtest results were standardized, and paper number 22 included past examples of their research. Paper number 24 was excluded because only participants with PDD-NOS were included in the study. Paper number 26 was excluded because of lack of similarities and Comprehension scores. Paper numbers 33,35,39,44 were excluded because of lack of Digit Span scores. Paper number 40 was excluded because the study did not include any verbal subtests. Paper number 41 was excluded because of lack of Vocabulary and Digit Span scores. Since paper numbers 49 and 50 seemed to examine the same participants, only paper number 49 was used and paper number 50 was excluded
M mean, ASD Autism Spectrum Disorder, FSIQ Full Scale Intelligence Quotient, PDD Pervasive Developmental Disorder, PDDNOS Pervasive Developmental Disorder Not Otherwise Specified, WAIS Wechsler Adult Intelligence Scale, WISC Wechsler Intelligence Scale for Children
§The mean Age in Mouga was calculated by summing all cases
Mean scores of six subtests, diagnostic criteria, and diagnosis of the ultimate group analyzed
| Author(s) and Year of Publication | Test | FSIQ | Similarities | Vocabulary | Comprehension | Block Design | Digit Span | Coding | Diagnostic Criteria | Diagnosis | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bartak et al. ( | WISC | 9 | 3.8 | 4.1 | 2.7‡ | 12.4† | 7.2 | 7.7 | Rutter ( | Infantile autism | |
| Ohta ( | WISC | 16 | 72.1 | 4.4 | 4.4 | 1.4‡ | 10.6† | 6.1 | 6.6 | DSM-III | Infantile autism |
| Freeman et al. ( | WISC-R | 21 | 97.4 | 10.4 | 8.1 | 6.5‡ | 12.1† | 8.8 | 7.7 | DSM-III | Autistic children |
| Lincoln et al. ( | WISC-R | 13 | 68.5 | 4.2 | 1.9 | 1.4‡ | 10.2† | 5.2 | 4.8 | DSM-III | Infantile autism |
| Allen et al. ( | WISC-R | 20 | 68.4 | 3.7 | 2.3 | 1.3‡ | 11.2† | 5.0 | 4.4 | DSM-III-R | Autistic children |
| Siegel et al. ( | WISC-R | 45 | 96.0 | 10.6 | 9.0 | 7.5‡ | 11.3† | 9.6 | 7.5 | DSM-III-R | Autism |
Ehlers et al. ( Participant E1 | WISC-R | 40 | 78.8 | 8.2 | 6.8 | 6.3 | 9.1† | 7.8 | 5.5‡ | DSM-III/ DSM-III-R | Infantile autism/ Autistic disorder |
Ehlers et al. ( Participant E2 | WISC-R | 40 | 102.5 | 12.3† | 12.0 | 11.2 | 10.5 | 10.4 | 7.8‡ | Gillberg and Gillberg ( | Asperger syndrome |
| Manjiviona and Prior ( | WISC-R | 21 | 88.6 | 9.9 | 7.6 | 7.2 | 10.2† | 7.4 | 6.0‡ | DSM-III-R/ ICD-10 | Autism |
de Bruin et al. ( Participant B1 | WISC-R | 13 | 88.9 | 8.8† | 7.7 | 7.9 | 7.8 | 8.4 | 5.8‡ | DSM-IV | Autism |
de Bruin et al. ( Participant B2 | WISC-R | 11 | 106.3 | 12.5† | 11.1 | 9.1 | 10.5 | 9.5 | 6.6‡ | DSM-IV | Asperger syndrome |
| Nydēn et al. ( | WISC-III | 13 | 106.8 | 11.9 | 15.1† | 11.8‡ | 12 | 8.1 | 8.2 | DSM-IV§/ Gillberg ( | Asperger syndrome |
| Mayes and Calhoun ( | WISC-III | 93 | 103.0 | 12.2† | 11.4 | 9 | 11.6 | 8.9 | 7.5‡ | DSM-IV | Autism |
| Williams et al. ( | WISC-III | 38 | 103.8 | 12.1† | 11.3 | 7.5‡ | 11.7 | 10.4 | 8.4 | No description§ | Autism |
| Muraru et al. ( | WISC-III | 53 | 97.8 | 9.4 | 9.1 | 9.2 | 10.4† | 9.1 | 8.2‡ | DSM-IV | PDD |
| Zhang et al. ( | WISC-III | 135 | 92.9 | 9.3 | 8.8 | 8.4 | 9.4† | 8.9 | 7.7‡ | DSM-IV | PDD |
| Koyama and Kurita ( | WISC-III | 28 | 102.1 | 10.7 | 10.5 | 9.1 | 11.9 | 12.4† | 8.5‡ | DSM-IV | Asperger syndrome |
| Koyama et al. ( | WISC-III | 142 | 96.3 | 9.9 | 9.0 | 7.9‡ | 11.2† | 11.2 | 9.0 | DSM-IV/ ICD-10 | PDD |
Nader et al. ( Participant N1 | WISC-III | 51 | 90.6 | 9.6 | 7.2 | 5.2‡ | 12.2† | 8.0 | 6.8 | DSM-IV | Autism |
Nader et al. ( Participant N2 | WISC-III | 15 | 99.4 | 11.9 | 13.3† | 7.6 | 10.7 | 12.7 | 6.4‡ | DSM-IV | Asperger syndrome |
| Kumazaki et al. ( | WISC-III | 46 | 97.6 | 9.5 | 9.3 | 8.7‡ | 11† | 10.3 | 9.1 | DSM-IV/ ICD-10 | ASD |
Mouga et al. ( Participant M1 | WISC-III | 58 | 60.9 | 5.9 | 3.7 | 3.1‡ | 6.3† | 5.7 | 3.9 | DSM-5 | ASD |
| Mayes and Calhoun ( | WISC-IV | 54 | 101.0 | 12.9† | 11.5 | 9.3 | 11.6 | 8.4 | 6.6‡ | DSM-IV | Autism |
Foley-Nicpon et al. ( Participant F1 | WISC-IV | 18 | 120.3 | 13.6† | 13.3 | 11.4 | 12.8 | 11.9 | 9.5‡ | DSM-IV-TR | Autism |
Foley-Nicpon et al. ( Participant F2 | WISC-IV | 21 | 124.9 | 15.2 | 15.6† | 12.9 | 13.6 | 12.6 | 7.4‡ | DSM-IV-TR | Asperger syndrome |
| Oliveras-Rentas et al. ( | WISC-IV | 56 | 97.6 | 11.8† | 10.3 | 7.9 | 10.5 | 9.5 | 7.3‡ | DSM-IV | ASD |
| Kuriakose ( | WISC-IV | 23 | 80.0 | 8.4 | 7.0 | 4.9‡ | 9.5† | 7.4 | 5.7 | DSM-IV-TR | ASD |
| Matsuura et al. ( | WISC-IV | 11 | 105.4 | 11.7 | 10.4 | 9.8 | 12.2† | 11.9 | 9.2‡ | DSM-IV-TR | ASD |
Nader et al. ( Participant N3 | WISC-IV | 51 | 90.7 | 8.4 | 8.2 | 5.8‡ | 11† | 7.6 | 7.7 | DSM-IV | Autism |
Nader et al. ( Participant N4 | WISC-IV | 15 | 98.3 | 12.5 | 13.3† | 9.3 | 9.5 | 8.3 | 6.7‡ | DSM-IV | Asperger syndrome |
| Calero et al. ( | WISC-IV | 45 | 102.3 | 13.2† | 12.8 | 10.1 | 11.3 | 10.9 | 7.8‡ | No description§ | Asperger syndrome |
| Li et al. ( | WISC-IV | 32 | 94.4 | 10.7 | 8.1 | 8 | 12.3† | 8.9 | 7.7‡ | DSM-5 | ASD |
| Stack et al. ( | WISC-IV | 134 | 97.8 | 11.9† | 10.3 | 8.7 | 10.4 | 9.3 | 7.6‡ | DSM-IV-TR/ ICD-10 | ASD |
ASD Autism Spectrum Disorder, DSM Diagnostic and Statistical Manual of Mental Disorders, FSIQ Full Scale Intelligence Quotient, ICD International Classification of Disease and Related Health Conditions, PDD Pervasive Developmental Disorder, WISC Wechsler Intelligence Scale for Children
†Added to the highest score of the six subtests. ‡ Added to the lowest score of the six subtests
§This case included in Nydēn used “Asperger’s Syndrome” as its diagnostic name, it was further explained that ‟they also met DSM-IV criteria for Asperger’s Syndrome with the exception that language development and curiosity about the environment was not normal in all cases.” Williams and Calero did not describe the diagnostic criteria employed
Fig. 1Comparison of six subtest profiles of the three groups based on intellectual level. a Seven groups with a mean FSIQ of ≤ 85. b Sixteen groups with a mean FSIQ of ≥ 86 and < 100. c Eleven groups with a mean FSIQ of ≥ 100. The order of subtests in figures for this study followed the order in the present WISC-IV manual. ASD, Autism Spectrum Disorder; PDD, Pervasive Developmental Disorder; WISC, Wechsler Intelligence Scales for Children